Nutritional therapy of impaired glucose tolerance and diabetes mellitus

Nutritional Aspects and Clinical Management of Chronic Disorders and Diseases

Volumn , Issue , 2002, Pages 69-91

  Preuss, Harry G ^a   Bagchi, Debasis ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052968011     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (62)

1. Anderson RA. Recent advances in the clinical and biochemical effects of chromium deficiency, in Essential and Toxic Trace Elements in Human Health and Disease. Prasad AS (Ed.). New York:Wiley Liss, 1993, pp. 221-234.
2. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, and Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 46:1786-1791, 1997.
3. Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski A, Joshi SJ, and Preuss HG. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 148:187-197, 2000.
4. Baskaran K, Ahamath BK, ShanmugasundaramKR, and Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J. Ethnopharmacol. 30:295-300, 1990.
5. Breslow L. Prevention and control of noncommunicable diseases. World Health Forum. 3:429-431, 1982.
6. Cam MC, Brownsey RW, and McNeill JH. Mechanisms of vanadium action: insulinmimetic or insulin enhancing agent? Can. J. Physiol. Pharmacol. 78:829-847, 2000.
7. Caso EK. Calculation of diabetic diets. J. Am. Diet. Assoc. 26:575-583, 1950.
8. Cerami A, Vlassare H, and Brownlee M. Glucose and aging. Sci. Am. 256:90-96, 1987.
9. Chausmer AB. Zinc, insulin, and diabetes. J. Am. Coll. Nutr. 17:109-115, 1998.
10. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, and Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J. Clin. Invest. 95:2501-2509, 1995.
11. Davies S, Howard JM, Hunnisett A, and Howard M. Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients -implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism. Clinical and Experimental. 46:469-473, 1997.
12. DeFronzo RA and Ferinimmi E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:173-194, 1991.
13. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, and Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetes patients. Diabet. Med. 15:503-507, 1998.
14. Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, and Taylor KG. Sodium restriction and blood pressure in hypertensive type II diabetics: randomized blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. Br. Med. J. 298:226-230, 1989.
15. Dunn FL. Plasma lipid and lipoprotein disorders in IDDM. Diabetes. 41(Suppl 2):102-106, 1992.
16. Eliasson K, Ryttig KR, Hylander B, and Rossner S. A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial. J. Hypertens. 10:195-199, 1992.
17. Franz MJ, Horton ES, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, Henry RR, Hoogwerf BJ, and Stacpoole PW. Nutrition principles for the management of diabetes and related complications. Diabetes Care. 17:490-518, 1994.
18. Frost G, Keogh B, Smith D, Akinsanya K, and Leeds A. The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism. 45:669-672, 1996.
19. Fukagawa NK, Anderson JW, Hageman G, Young VR, and Ninaker KL. Highcarbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am. J. Clin. Nutr. 52:524-528, 1990.
20. Gallaher DD, Csallany AS, Shoeman DW, and Olson JM. Diabetes increases excretion of urinary malonaldehyde conjugates in rats. Lipids. 28:663-666, 1993.
21. Garg A, Bonanome A, Grundy SM, Zhang AJ, and Unger RH. Comparison of a highcarbohydrate diet with high-monosaturated fat diet in patients with non-insulin dependent diabetes mellitus. N. Engl. J. Med. 391:829-834, 1988.
22. Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D’Episcopo L, and Riccardi G. Long-term dietary treatment with increased amounts of fiber-rich lowglycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type I diabetic patients. Diabetes Care. 23:1461-1466, 2000.
23. Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang Z, Willsky GR, and Kahn CR. Metabolic effects of vanadyl sulfate in humans with noninsulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism. 49:400-410, 2000.
24. Harris MI. Impaired glucose tolerance in the US population. Diabetes Care. 14:628-638, 1991.
25. Harris MI, Hadden WC, Knowler WC, and Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74. Diabetes. 36:523-534, 1987.
26. Henry RR. Protein content of the diabetic diet. Diabetes Care. 17:1502-1517, 1994.
27. Holler HJ and Pastors JG. Diabetes Medical Nutrition Therapy. Chicago, American Dietetic Association, 1997, pp. 99-123.
28. Horton ES and Napoli R. Diabetes mellitus, in Present Knowledge in Nutrition, 7th ed. EE Ziegler and LJ Filer, Jr. (Eds.) ILSI Press, Washington, D.C., 1996, pp. 445-455.
29. Hu FB, van Dam RM, and Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 44:805-817, 2001.
30. Jenkins DJA, Wolever TMS, and Jenkins AL. Starchy foods and glycemic index. Diabetes Care. 11:149-159, 1988.
31. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, and Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 159:2119-2120, 1999.
32. Katsilambros NL. Nutrition in diabetes mellitus. Exp. Clin. Endocrinol. Diabetes. 109:S250-S258, 2001.
33. Kelly GS. Insulin resistance: lifestyle and nutritional interventions. Altern. Med. Rev. 5:109-132, 2000.
34. King H, Aubert RE, and Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 21:1414-1431, 1998.
35. Landin K, Holm G, Tengborn L, and Smith U. Guar guar improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am. J. Clin. Nutr. 56:1061-1065, 1992.
36. Mertz W. Chromium in human nutrition: a review. J. Nutr. 123:626-633, 1993.
37. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgay M, Vinicor F, and Marks JS. Diabetes trends in the US: 1990-1998. Diabetes Care. 23:1278-1283, 2000.
38. National Diabetes Data Group: classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057, 1979.
39. O’Connell B. The diabetes connection: botanicals with hypoglycemic activity. Nutraceuticals World. May: 28-38, 2000.
40. Orvig C, Thompson KH, Batrtell M, and McNeill JH. The essentiality and metabolism of vanadium, in Metal Ions in Biological Systems, Vol 31, Vanadium and Its Role in Life. Sigel H and Sigel A (Eds.) Marcel Dekker, New York, 1995, pp. 575-594.
41. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, and Elahi D. Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism. 34:199-204, 1985.
42. Preuss HG. Sodium, chloride and potassium, in Present Knowledge in Nutrition. BA Bowman and RM Russell (Eds.) ILSI Press: Washington, D.C., 2001, pp. 302-310.
43. Preuss HG, Bagchi D, and Clouatre D. Insulin resistance; a factor in aging, in The Advanced Guide to Longevity Medicine. Ghen MJ et al. (Eds.) Ghen, Landrum SC, 2001, pp. 239-250.
44. Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, and Anderson RA. Effect of chromium and guar on sugar-induced hypertension in rats. Clin. Neph. 44:170-177, 1995.
45. Preuss HG, Talpur N, Fan AY, Bagchi M, and Bagchi D. Treating impaired glucose tolerance and diabetes mellitus via nutrition and dietary supplement. The Original Internist. 8:4, 17-23, 42-44, December 2001.
46. Preuss HG, Zein M, Knapka J, and DiPette, D. Effects of heavy sugar eating on three strains of Wistar rats over their lifespan. J. Am. Coll. Nutr. 17:36-47, 1998.
47. Reaven GM. Role of insulin resistance in human disease (Banting Lecture 1988). Diabetes. 37:1595-1607, 1988.
48. Reiser S, Handler HB, Gardner LB, Hallfrisch JG, Michaelis OE, and Prather ES. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am. J. Clin. Nutr. 32:2206-2216, 1979.
49. Ryan M, McInerney D, Owens D, Collins P, Johnson A, and Tomkin GH. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. Quart. J. Med. 93:85-91, 2000.
50. Sartor G, Schersten B, Carlstrom S, Melandor A, Nordan A, and Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes. 29:41-49, 1980.
51. Shanmugasundaram ER, Rajeswari G, Baskaran K, Kumar BRR, Shanmugasundaram KR, and Ahmath BK. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J. Ethnopharmacol. 30:281-294, 1990.
52. Stearns DM, Wise JP Sr, Patierno SR, and Wetterhahn KE. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovarian cells. FASEB J. 9:1643-1648, 1995.
53. Sun Y, Ramirez J, Woski SA, and Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. J. Biol. Inorg. Chem. 5:129-136, 2000.
54. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin dependent diabetes mellitus. N. Engl. J. Med. 329:977-986, 1993.
55. Therapeutic Research Faculty. Natural Medicines. Comprehensive Database. Stockton CA, 2001.
56. Timar O, Sestier F, and Levy E. Metabolic syndrome X: a review. Can. J. Cardiol. 16:779-789, 2000.
57. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, and Uusitupa M. Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:1390-1392, 2001.
58. Virtanen SM and Aro A. Dietary factors in the aetiology of diabetes. Ann. Med. 26:469-478, 1994.
59. Wheeler ML. Nutrition management and physical activity as treatments for diabetes. Primary Care; Clinics in Office Practice. 26:857-868, 1999.
60. Yudkin J. Sucrose, coronary heart disease, diabetes, and obesity. Do hormones provide a link? Am. Heart J. 115:493-498, 1988.
61. Zammit VA, Waterman IJ, Topping D, and McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J. Nutr. 131:2074-2077, 2001.
62. Zimmet PZ. Primary prevention of diabetes mellitus. Diabetes Care. 11:258-262, 1988.